Downloads provided by UsageCounts
handle: 10261/123868 , 10261/123871
La presente invención se refiere al uso del factor de crecimiento insulínico tipo 1 (IGF-1) como reactivo de diagnóstico y/o pronóstico precoz de la enfermedad de Alzheimer, así como a un kit que comprende IGF-1 y un sedante y su uso en el diagnóstico y/o pronóstico precoz de la enfermedad de Alzheimer.
Consejo Superior de Investigaciones Científicas, Universidad Autónoma de Madrid
A1 Solicitud de patente con informe sobre el estado de la técnica
Peer reviewed
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
| views | 42 | |
| downloads | 57 |

Views provided by UsageCounts
Downloads provided by UsageCounts